Arrowstreet Capital, Limited Partnership Rvl Pharmaceuticals PLC Transaction History

Arrowstreet Capital, Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.8 - $3.78 $105,593 - $142,551	-37,712 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.26 - $4.84 $582,079 - $864,191	-178,552 Reduced 82.56%	37,712 $123,000
Q4 2020 Feb 12, 2021	SELL	$4.12 - $6.29 $477,219 - $728,570	-115,830 Reduced 34.88%	216,264 $891,000
Q3 2020 Nov 12, 2020	BUY	$4.82 - $8.77 $901,879 - $1.64 Million	187,112 Added 129.06%	332,094 $1.8 Million
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $272,468 - $599,774	85,682 Added 144.49%	144,982 $461,000
Q4 2019 Feb 13, 2020	BUY	$3.46 - $7.7 $205,178 - $456,610	59,300 New	59,300 $415,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.